menu Search
Search Drug Information, Images & Medical News

Search Drug Information, Images & Medical News | MIMS Singapore

Advanced Search

 

MORE
JoyAge programme reduces depressive and anxiety symptoms and loneliness in older adults 14 Jul 2026

JoyAge, an integrated prevention programme, has effectively reduced symptoms of depression and anxiety as well as loneliness in older adults in Hong Kong, a pragmatic quasi-experimental trial has shown.
Contraceptive progestogens carry meningioma risk
14 Jul 2026
Patients with MASLD face heightened diabetes risk
14 Jul 2026
Eating low-sweet snacks, caregiver education reduce children’s sugar intake
14 Jul 2026
AI-supported digital microscopy improves lab diagnostics in primary healthcare
14 Jul 2026
Calcium-enriched permeate supplement prevents bone loss in postmenopausal women
14 Jul 2026
Is whole goat milk formula protective against AD in infants?
14 Jul 2026
Cagrilintide–semaglutide improves glycaemic control in early-stage diabetes
13 Jul 2026
Tackling the increasing threat of MBL-producing pathogens and S. maltophilia: Key insights from ESCMID Global 2026
13 Jul 2026
Nipocalimab shows rapid, durable Hgb improvements in adults with wAIHA
13 Jul 2026
Topical ivermectin, encapsulated benzoyl peroxide come first among rosacea medications
13 Jul 2026
MORE
Tackling the increasing threat of MBL-producing pathogens and S. maltophilia: Key insights from ESCMID Global 2026 13 Jul 2026;
Antimicrobial resistance (AMR) continues to challenge healthcare systems worldwide, with carbapenem-resistant Gram-negative infections among the most urgent clinical threats. At a symposium held during ESCMID Global 2026, Dr Subramanian Swaminathan (India), Dr Paula Ramírez (Spain), Prof Gian Maria Rossolini (Italy), Prof Garyfallia Poulakou (Greece), and Prof Michele Bartoletti (Italy) explored the epidemiology, diagnosis, and management of infections caused by metallo-β-lactamase (MBL)-producing organisms, with a particular focus on carbapenem-resistant Enterobacterales (CRE) and Stenotrophomonas maltophilia.
‘For the Reasons that Matter’ Campaign spotlights adult respiratory health across Malaysia, Indonesia, Singapore, and the Philippines
05 Jun 2026
Addressing the vaping epidemic: Policy and clinical observations to facilitate cessation
28 May 2026
Apixaban vs rivaroxaban for acute VTE: Insights from 1st head-to-head randomised trial
06 May 2026
SHOW ALL

New Molecule

1 New

New Indication

1 New

Markings
Shape
Form
Color 1
Color 2
Advertisement
MORE
Infant Skin Barrier Protection: Clinical Evidence for Nutritional Intervention in Atopic Dermatitis Prevention
Doctors Cat3B: 1 point
Good Jab: Vaccine Advocacy for Vaccine-Preventable Respiratory Infections Among Adult At-Risk Populations 
Doctors Cat 3B: 1 point
RSV in infants: A comprehensive guide from disease to treatment
Doctors Cat3B: 1 point
Advertisement
Advertisement

MIMS is a trusted, accurate and user-friendly medication information platform. Designed to empower both healthcare professionals and general public to support informed healthcare decisions, our leading drug directory provides clear, reliable information on prescription drugs, over-the-counter medications and other medical resources.

Learn More About Us

Frequently Asked Questions

Absolutely. Our database is continuously updated by medical editors and references authoritative sources, ensuring accuracy and credibility.

Yes. You can access MIMS.com on desktop or mobile, and we also offer an app for on-the-go use.

Use the search bar located at the top of the homepage and enter either the brand name or generic name of the drug.

Go to "Diseases" and use the search bar located at the top of the page and enter the name of the disease.

Go to "Medical News & Updates" to access latest news and medical updates in MIMS.com
Explore More FAQs